Efficacy of the atypical antipsychotic aripiprazole in d-amphetamine-based preclinical models of mania

International Journal of Neuropsychopharmacology

Volumn 13, Issue 4, 2010, Pages 541-548

  Mavrikaki, Maria ^a   Nomikos, George G ^b   Panagis, George ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b TAKEDA PHARMACEUTICALS   (United States)

Author keywords

Animal model; Behavioural sensitization; Brain stimulation reward; Mood stabilizers

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; DEXAMPHETAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; DRIVE; DRUG EFFICACY; FACILITATION; LOCOMOTION; MALE; MANIA; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT; REWARD; SELF STIMULATION; SENSITIZATION;

ANIMALS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CENTRAL NERVOUS SYSTEM STIMULANTS; DEXTROAMPHETAMINE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; LOCOMOTION; MALE; PIPERAZINES; QUINOLONES; RATS; RATS, SPRAGUE-DAWLEY; SELF STIMULATION;

EID: 77953536972     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145709991143     Document Type: Article

References (29)

1. Altamura AC (2007). Bipolar spectrum and drug addiction. Journal of Affective Disorders 99, 285.
2. Angrist B, Corwin J, Bartlik B, Cooper T (1987). Early pharmacokinetics and clinical effects of oral D-amphetamine in normal subjects. Biological Psychiatry 22, 1357-1368.
3. Belmaker RH (2004). Bipolar disorder. New England Journal of Medicine 351, 476-486.
4. Beresford TP, Clapp L, Martin B, Wiberg JL, et al. (2005). Aripiprazole in schizophrenia with cocaine dependence: a pilot study. Journal of Clinical Psychopharmacology 25, 363-366.
5. Eckermann K, Beasley A, Yang P, Gaytan O, et al. (2001). Methylphenidate sensitization is modulated by valproate. Life Sciences 69, 47-57.
6. Einat H (2006). Modelling facets of mania-new directions related to the notion of endophenotypes. Journal of Psychopharmacology 20, 714-722.
7. Einat H, Manji HK, Belmaker RH (2003). New approaches to modeling bipolar disorder. Psychopharmacology Bulletin 37, 47-63.
8. Feltenstein MW, Altar CA, See RE (2007). Aripiprazole blocks reinstatement of cocaine seeking in an animal model of relapse. Biological Psychiatry 61, 582-590.
9. Flagstad P, Arnt J, Olsen CK (2006). Classical as well as novel antipsychotic drugs increase self-stimulation threshold in the rat-similar mechanism of action? European Journal of Pharmacology 544, 69-76.
10. Gallistel CR, Karras D (1984). Pimozide and amphetamine have opposing effects on the reward summation function. Pharmacology Biochemistry and Behavior 20, 73-77.
11. Hasler G, Drevets WC, Gould TD, Gottesman II, et al. (2006). Toward constructing an endophenotype strategy for bipolar disorders. Biological Psychiatry 60, 93-105.
12. Jacobs D, Silverstone T (1986). Dextroamphetamine-induced arousal in human subjects as a model for mania. Psychological Medicine 16, 323-329.
13. Jerlhag E (2008). The antipsychotic aripiprazole antagonizes the ethanol-and amphetamine-induced locomotor stimulation in mice. Alcohol 42, 123-127.
14. Leite JV, Guimaraes FS, Moreira FA (2008). Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice. European Journal of Pharmacology 578, 222-227.
15. Lile JA, Stoops WW, Vansickel AR, Glaser PE, et al. (2005). Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of D-amphetamine in humans. Neuropsychopharmacology 30, 2103-2114.
16. Mavrikaki M, Nomikos GG, Panagis G (2009). Effects of mood stabilizers on brain reward processes in rats: studies using the intracranial self-stimulation paradigm. European Neuropsychopharmacology 19, 205-214.
17. Newton TF, Reid MS, De La Garza R, Mahoney JJ, et al. (2008). Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers. International Journal of Neuropsychopharmacology 11, 1037-1045.
18. Nordquist RE, Risterucci C, Moreau JL, von Kienlin M, et al. (2008). Effects of aripiprazole/OPC-14597 on motor activity, pharmacological models of psychosis, and brain activity in rats. Neuropharmacology 54, 405-416.
19. Paxinos G, Watson C (2007). The Rat Brain in Stereotaxic Coordinates. Amsterdam: Elsevier.
20. Predy PA, Kokkindis L (1984). Sensitization to the effects of repeated amphetamine administration on intracranial self-stimulation: evidence for changes in reward processes. Behavioural Brain Research 13, 251-259.
21. Shapiro DA, Renock S, Arrington E, Chiodo LA, et al. (2003). Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology 28, 1400-1411.
22. Sorensen G, Sager TN, Petersen JH, Brennum LT, et al. (2008). Aripiprazole blocks acute self-administration of cocaine and is not self-administered in mice. Psychopharmacology (Berlin) 199, 37-46.
23. Stoops WW (2006). Aripiprazole as a potential pharmacotherapy for stimulant dependence: human laboratory studies with d-amphetamine. Experimental and Clinical Psychopharmacology 14, 413-421.
24. Stoops WW, Lile JA, Glaser PE, Rush CR (2006). A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine. Drug and Alcohol Dependence 84, 206-209.
25. Strakowski SM, Sax KW, Setters MJ, Keck Jr. PE (1996). Enhanced response to repeated d-amphetamine challenge: evidence for behavioral sensitization in humans. Biological Psychiatry 40, 872-880.
26. Thomsen M, Fink-Jensen A, Woldbye DP, Wortwein G, et al. (2008). Effects of acute and chronic aripiprazole treatment on choice between cocaine self-administration and food under a concurrent schedule of reinforcement in rats. Psychopharmacology (Berlin) 201, 43-53.
27. Tomasiewicz HC, Mague SD, Cohen BM, Carlezon Jr. WA (2006). Behavioral effects of short-term administration of lithium and valproic acid in rats. Brain Research 1093, 83-94.
28. Wee S, Wang Z, Woolverton WL, Pulvirenti L, et al. (2007). Effect of aripiprazole, a partial dopamine D2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration. Neuropsychopharmacology 32, 2238-2247.
29. White FJ, Wang RY (1984). Electrophysiological evidence for A10 dopamine autoreceptor subsensitivity following chronic D-amphetamine treatment. Brain Research 309, 283-292.